Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

8.170 +0.350 (+4.48%)

Official Closing Price Updated: 7:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

2 Cathie Wood Biotech Stocks That Could Be Worth the Risk ↗

May 29, 2024

You don't need to buy her picks, but it's worth understanding them.

Via The Motley Fool

Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF ↗

May 28, 2024

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings.

Via Benzinga

Topics ETFs

3 Things You Need to Know if You Buy Ginkgo Bioworks Today ↗

May 25, 2024

It needs to work within the constraints imposed by these three issues.

Via The Motley Fool

Down 72%. Is Ginkgo Bioworks a Buy on the Dip? ↗

May 25, 2024

The number of cell engineering partnerships Ginkgo Bioworks has is way up, but the same can't be said about its stock price.

Via The Motley Fool

How Is The Market Feeling About Ginkgo Bioworks Holdings? ↗

May 23, 2024

Via Benzinga

Is Ginkgo Bioworks Holdings Stock a Buy? ↗

May 18, 2024

Can this struggling stock turn things around?

Via The Motley Fool

Ginkgo Bioworks: Buy, Sell, or Hold? ↗

April 30, 2024

This company has a long way to go before investors will see rewards.

Via The Motley Fool

Looking Into Ginkgo Bioworks Holdings's Recent Short Interest ↗

April 26, 2024

Via Benzinga

Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst ↗

May 20, 2024

Ginkgo Bioworks has become a penny stock -- and that's the least of its problems,

Via The Motley Fool

Investment Advisor Says 'Throwing Random Darts At Tickers' Would Beat ARKK As Cathie Wood's Flagship Fund Lags Far Behind Soaring Market: 'How Do They Do It?!' ↗

May 20, 2024

Ram Ahluwalia of Lumida Wealth pointed to Ark's flagship ETF trading over 70% below its all-time high amid the S&P 500's recent record highs.

Via Benzinga

Topics ETFs Stocks

4 Small-Cap Value Stocks That Could Go Parabolic ↗

May 16, 2024

These four small-cap stocks scan as deeply undervalued right now.

Via The Motley Fool

What's the Difference Between Biotech Stocks and TechBio Stocks? ↗

May 15, 2024

A few enterprising businesses are marketing themselves differently.

Via The Motley Fool

TeraWulf Posts Weak Results, Joins StoneCo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

May 14, 2024

Via Benzinga

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 10, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 10, 2024

The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning!

Via InvestorPlace

Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

May 10, 2024

Via Benzinga

DNA Stock Earnings: Ginkgo Bioworks Holdings Meets EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

DNA stock results show that Ginkgo Bioworks Holdings met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Ginkgo Bioworks Stock Falls On Disappointing Q1 Sales: 'This Trend Needs To Change' ↗

May 09, 2024

Ginkgo Bioworks reported quarterly sales of $38 million which missed the analyst consensus estimate of $46.044 million by 17.47% and is a 52.91% decrease in sales year-over-year. The company said the...

Via Benzinga

3 Meme Stocks to Sell in May Before They Crash & Burn ↗

May 08, 2024

Traders have gravitated to meme stocks over the past year. But it's time to sell these three before the party ends.

Via InvestorPlace

Want $10,000? Invest $1,000 in These 3 Penny Stocks Now ↗

May 07, 2024

Let's dive into these three high-potential penny stocks to discover whether or not they offer genuine investment opportunities.

Via InvestorPlace

Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today? ↗

April 30, 2024

Cyclacel Pharmaceuticals stock is up on Tuesday with heavy trading of CYCC shares after the company withdrew a public offering.

Via InvestorPlace

Is a Giant Short Squeeze in Ginkgo Bioworks (DNA) Stock? ↗

April 29, 2024

DNA stock is up 15% today for little reason, fueling speculation that Ginkgo Bioworks may be in the midst of a short squeeze.

Via InvestorPlace

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 29, 2024

Via Benzinga

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗

April 29, 2024

Via Benzinga

Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks. ↗

April 15, 2024

The collaboration could help solve challenges for both businesses.

Via The Motley Fool

What's Going On With Ginkgo Bioworks Stock? ↗

April 11, 2024

Ginkgo Bioworks announced the expansion of its strategic partnership with Novo Nordisk A/S on Wednesday under a framework agreement that initially is contemplated to run over five years.Ginkgo said the...

Via Benzinga

Bull Market and Beyond: 3 Stocks Just Waiting to Soar ↗

April 09, 2024

These stocks, a bargain today, are players to hold on to for the long term.

Via The Motley Fool

The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation ↗

April 08, 2024

They might not be profitable yet, but they're swinging for the fences.

Via The Motley Fool

Topics Artificial Intelligence

2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now? ↗

April 03, 2024

These stocks could rocket higher, but they also present significant risks.

Via The Motley Fool

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 28, 2024

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Starting at $3.75/week.

Subscribe Today